Squarepoint’s Fortress Biotech FBIO Stock Holding History

Squarepoint’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$47.1K	Buy	+15,381	New	+$39.7K	﹤0.01%	4270
2021 Q3	–	Sell	-3,533	Closed	-$189K	–	3059
2021 Q2	$189K	Buy	3,533 +251	+8%	+$15.1K	﹤0.01%	2856
2021 Q1	$174K	Buy	3,282 +840	+34%	+$47.4K	﹤0.01%	2750
2020 Q4	$116K	Sell	2,442 -1,424	-37%	-$61.7K	﹤0.01%	2688
2020 Q3	$234K	Sell	3,866 -528	-12%	-$26.9K	﹤0.01%	1990
2020 Q2	$177K	Buy	+4,394	New	+$163K	﹤0.01%	1859
2015 Q2	–	Sell	-1,907	Closed	-$110K	–	505
2015 Q1	$110K	Buy	+1,907	New	+$79.5K	0.04%	397

Other funds holding FBIO

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Squarepoint's FBIO Position: Q2 2026 in Review

Squarepoint opened a new position in Fortress Biotech (FBIO) in Q2 2026: 15,381 shares worth $47.1K. The stake represents ﹤0.01% of the portfolio and ranks #4270 among its holdings. This is a return to the name: Squarepoint previously reported a position in FBIO as recently as Q2 2021.

Squarepoint first reported a position in FBIO in Q1 2015 and has held it in 7 quarters since. The position peaked at $234K in Q3 2020. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

Squarepoint held 15,381 shares of Fortress Biotech worth $47.1K as of Q2 2026.
Fortress Biotech was a new Squarepoint position in Q2 2026.
Fortress Biotech made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #4270 holding.
Squarepoint first reported a position in Fortress Biotech in Q1 2015 and has held it in 7 quarters since.
Squarepoint's Fortress Biotech position peaked at $234K in Q3 2020.
55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.